Brainsway Starts Multicenter Clinical Trial for Bipolar Disorder

Published: Aug 21, 2012

JERUSALEM, Aug. 21, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (BRIN.TA) is pleased to announce that, further to its press release of November 1, 2011, the Company has contracted with 18 medical research centers, mainly in the United States, Canada and Israel, to participate in its multicenter clinical trial to evaluate the efficacy of its Deep TMS device in the treatment of biopolar disorder. To-date, of those 18 participating centers, seven have begun patient recruitment.

Back to news